Muhammad Baluom is a seasoned expert in clinical pharmacology and pharmacokinetics with extensive experience spanning over two decades. Currently serving as the Executive Director of Clinical Pharmacology at Eli Lilly and Company, Muhammad has held various leadership positions, including Senior Director of Clinical Pharmacology at DICE Therapeutics and Director of Clinical Pharmacology at Nektar Therapeutics. Prior roles include Director of Clinical Pharmacology/Pharmacokinetics at Rigel Inc. and Clinical Pharmacokinetics and Pharmacology Consultant. In addition to consultancy and industry roles, Muhammad is a trustee for the San Mateo County Mosquito and Vector Control District, representing the city of Millbrae. Muhammad's educational background includes a Post-Doctoral degree in Pharmacokinetics and a PhD in Pharmaceutics and Pharmacokinetics from The Hebrew University of Jerusalem.
This person is not in the org chart
This person is not in any teams
This person is not in any offices